APP
WST icon

Alpha Paradigm Partners’s West Pharmaceutical WST Stock Holding History

Alpha Paradigm Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-658
Closed -$199K – 651
2022
Q2 		$199K Hold
658
– – 0.08% 322
2022
Q1 		$270K Sell
658
-87
-12% -$34.1K 0.11% 289
2021
Q4 		$349K Hold
745
– – 0.14% 252
2021
Q3 		$316K Sell
745
-43
-5% -$18.1K 0.13% 257
2021
Q2 		$283K Sell
788
-388
-33% -$128K 0.11% 300
2021
Q1 		$331K Buy
1,176
+760
+183% +$218K 0.13% 236
2020
Q4 		$118K Buy
+416
New +$117K 0.04% 310

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alpha Paradigm Partners's WST Position: Q3 2022 in Review

Alpha Paradigm Partners sold out of West Pharmaceutical (WST) in Q3 2022, closing a stake of 658 shares — an estimated $199K sold.

Alpha Paradigm Partners first reported a position in WST in Q4 2020 and held it in 7 quarters. The position peaked at $349K in Q4 2021. 637 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • Alpha Paradigm Partners reported no remaining West Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Alpha Paradigm Partners sold 658 West Pharmaceutical shares in Q3 2022, an estimated $199K.
  • Alpha Paradigm Partners first reported a position in West Pharmaceutical in Q4 2020 and held it in 7 quarters.
  • Alpha Paradigm Partners's West Pharmaceutical position peaked at $349K in Q4 2021.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Alpha Paradigm Partners's 13F filing for Q3 2022, filed 15 Nov 2022.